28 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/28/2854508/16626/en/Zevra-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Updates.html
26 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/journal-frontiers-in-psychiatry-publishes-analysis-of-open-label-safety-study-showing-improvements-in-sleep-habits-for-children-with-adhd-after-treatment-with-azstarys-serdexmethylphenidate-and-dexmethylphenidate-301862645.html
22 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coriums-novel-adhd-medication-azstarys-serdexmethylphenidate-and-dexmethylphenidate-had-no-clinically-significant-impact-on-childrens-weight-and-height-growth-rate-301830739.html
22 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coriums-novel-adhd-medication-azstarys-serdexmethylphenidate-and-dexmethylphenidate-shown-safe-and-effective-in-long-term-study-301752562.html
18 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/18/2559035/16626/en/KemPharm-Receives-FDA-Orphan-Drug-Designation-for-Serdexmethylphenidate-SDX-for-the-Treatment-of-Idiopathic-Hypersomnia-IH.html
13 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/corium-to-present-positive-data-on-adhd-medication-azstarys-serdexmethylphenidate-and-dexmethylphenidate-and-alzheimers-disease-medication-adlarity-donepezil-transdermal-system-at-psych-congress-2022-301622663.html
LOOKING FOR A SUPPLIER?